High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?

References

• Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–82
   PubMed Web of Science ®Google Scholar
• Asunción M, Calvo RM, San Millán JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–8
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Shi Y. Polycystic ovary syndrome. Front Med China 2010;4:280–4
   PubMedGoogle Scholar
• Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004;60:1–17
   PubMed Web of Science ®Google Scholar
• Fénichel P, Gobert B, Carré Y, et al. Polycystic ovary syndrome in autoimmune disease. Lancet 1999;353:2210
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–34
   PubMed Web of Science ®Google Scholar
• Hayashi N, Tamaki N, Konishi J, et al. Sonography of Hashimoto’s thyroiditis. J Clin Ultrasound 1986;14:123–6
   PubMed Web of Science ®Google Scholar
• Erdogan M, Erdem N, Cetinkalp S, et al. Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine 2009;36:486–90
   PubMed Web of Science ®Google Scholar
• Balázs C. The role of hereditary and environmental factors in autoimmune thyroid diseases. Orv Hetil 2012;153:1013–22
   PubMedGoogle Scholar
• Zaletel K, Gaberšček S. Hashimoto’s thyroiditis: from genes to the disease. Curr Genomics 2011;12:576–88
   PubMed Web of Science ®Google Scholar
• Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med 2013;6:880–9
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348:2646–55
   PubMed Web of Science ®Google Scholar
• Erdoğan MF, Demir O, Emral R, et al. More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region. Thyroid 2009;19:265–8
   PubMed Web of Science ®Google Scholar
• Brown MC, Spencer R. Thyroid gland volume estimated by use of ultrasound in addition to scintigraphy. Acta Radiol Oncol Radiat Phys Biol 1978;17:337–41
   PubMed Web of Science ®Google Scholar
• Kahsar-Miller MD, Nixon C, Boots LR, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75:53–8
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Alexandraki K, Bergiele A, et al. Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance. J Endocrinol Invest 2004;27:931–6
   PubMed Web of Science ®Google Scholar
• Ghosh S, Kabir SN, Pakrashi A, et al. Subclinical hypothyroidism: a determinant of polycystic ovary syndrome. Horm Res 1993;39:61–6
   PubMed Web of Science ®Google Scholar
• Wakim AN, Polizotto SL, Burholt DR. Augmentation by thyroxine of human granulosa cell gonadotrophin-induced steroidogenesis. Hum Reprod 1995;10:2845–8
   PubMed Web of Science ®Google Scholar
• Sridhar GR, Nagamani G. Hypothyroidism presenting with polycystic ovary syndrome. J Assoc Physicians India 1993;41:88–90
   PubMedGoogle Scholar
• Ganie MA, Marwaha RK, Aggarwal R, Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol 2010;162:1117–22
   PubMed Web of Science ®Google Scholar
• Tarkun I, Cetinarslan B, Türemen E, et al. Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat Disord 2006;4:122–8
   PubMedGoogle Scholar
• Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, et al. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecol Endocrinol 2008;24:378–84
   PubMed Web of Science ®Google Scholar
• Dardzińska JA, Rachoń D, Kuligowska-Jakubowska M, et al. Effects of metformin or an oral contraceptive containing cyproterone acetate on serum c-reactive protein, interleukin-6 and soluble vascular cell adhesion molecule-1 concentrations in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2014;122:118–25
   PubMed Web of Science ®Google Scholar
• Hefler-Frischmuth K, Walch K, Huebl W, et al. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril 2010;93:2291–4
   PubMed Web of Science ®Google Scholar
• Reimand K, Talja I, Metsküla K, et al. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol 2001;51:167–76
   PubMed Web of Science ®Google Scholar
• Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352–6
   PubMedGoogle Scholar
• Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004;150:363–9
   PubMed Web of Science ®Google Scholar
• Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012;285:853–6
   PubMed Web of Science ®Google Scholar
• Sinha U, Sinharay K, Saha S, et al. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab 2013;17:304–9
   PubMedGoogle Scholar
• Cakir E, Sahin M, Topaloglu O, et al. The relationship between LH and thyroid volume in patients with PCOS. J Ovarian Res 2012;5:43
   PubMedGoogle Scholar
• Petríková J, Figurová J, Dravecká I, Lazúrová I. Is polycystic ovary syndrome associated with autoimmune thyroiditis? Vnitr Lek 2012; 58:830–3
   PubMedGoogle Scholar
• Anaforoglu I, Topbas M, Algun E. Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity. J Endocrinol Invest 2011;34:e259–64
   PubMed Web of Science ®Google Scholar
• Garelli S, Masiero S, Plebani M, et al. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;169:248–251
   PubMed Web of Science ®Google Scholar
• Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993; 11:157–62
   PubMed Web of Science ®Google Scholar
• Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J Immunol 1991;146:4362–7
   PubMed Web of Science ®Google Scholar
• Angstwurm MW, Gärtner R, Ziegler-Heitbrock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997; 9:370–4
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635–8
   PubMed Web of Science ®Google Scholar
• Challis JR, Lockwood CJ, Myatt L, et al. Inflammation and pregnancy. Reprod Sci 2009;16:206–15
   PubMed Web of Science ®Google Scholar
• Pacifici R, Brown C, Puscheck E, et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991;88:5134–8
   PubMed Web of Science ®Google Scholar
• Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010;120:105–15
   PubMed Web of Science ®Google Scholar
• Pállinger E, Csaba G. A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells. Immunology 2008;123:584–9
   PubMed Web of Science ®Google Scholar
• Klecha AJ, Genaro AM, Gorelik G, et al. Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J Endocrinol 2006; 189:45–55
   PubMed Web of Science ®Google Scholar
• Klecha AJ, Genaro AM, Lysionek AE, et al. Experimental evidence pointing to the bidirectional interaction between the immune system and the thyroid axis. Int J Immunopharmacol 2000;22:491–500
   PubMed Web of Science ®Google Scholar
• Bittencourt CS, Azzolini AE, Ferreira DA, Assis-Pandochi AI. Antibody responses in hyperthyroid rats. Int Immunopharmacol 2007;7:989–93
   PubMed Web of Science ®Google Scholar
• Hodkinson CF, Simpson EE, Beattie JH, et al. Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55–70 years. J Endocrinol 2009;202:55–63
   PubMed Web of Science ®Google Scholar